:


Barakat RR et al: Corpus epithelial tumors, in Principles and Practice of Gynecologic Oncology, 2d ed., WJ Hoskins et al. (eds). Philadelphia, Lippincott, 1996, pp 859-896

Berek JS, Hacher NF, eds. Practical gynecologic oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins 2000.

Bolis G et al: EMA/CO regimen in high-risk gestational tropho-blastic tumor (GTT). Gynecol Oncol 31:439, 1988

Cressman WT, Disaia PJ: Screening in ovarian cancer. Am J Obstet Gynecol 165:7, 1991

Goldstein DP: Gestational trophoblastic neoplasia in the 1990's. Yale J Biol Med 64:639, 1991

Hacker NF: Uterine cancer, in Practical Gynecologic Oncology, 2d ed., JS Berek, NF Hacker (eds). Baltimore, Williams & Wilkins, 1994, pp 285-326.

McGuire WP et al: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1, 1996

Ozols RF et al: Epithelial ovarian cancer, in Principles and Practice of Gynecologic Oncology, 2d ed., WJ Hoskins et al. (eds). Philadelphia, Lippincott, 1996, pp 919-986

Soper VT: Identification and management of high-risk gestational trophoblastic disease. Semin Oncol 22:172, 1995

Stehman FB et al: Uterine cervix, in Principles and Practice of Gynecologic Oncology, 2d ed., WJ Hoskins et al. (eds). Philadelphia, Lippincott, 1996, pp 785-857

Vanderburg ME et al: Intervention debulking surgery does improve survival in advanced epithelial ovarian cancer. N Engl J Med 332:629, 1995

Williams S et al: Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide andbleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 12:701, 1994

Young RC et al: Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective trials. N Engl J Med 322:1021, 1990

:

  • :
  • :